Philip Herman
Corporate Officer/Principal chez REPARE THERAPEUTICS INC.
Fortune : 12 361 $ au 30/04/2024
Profil
Philip Karl Herman is currently the Executive VP-Commercial & New Product Development at Repare Therapeutics, Inc. He previously worked as the Marketing Director at Vanda Pharmaceuticals, Inc. and as the Vice President, Head-Commercial & Marketing at Dyax Corp.
From 2018 to 2021, he served as the Chief Commercial Officer & Senior Vice President at Y-mAbs Therapeutics, Inc. Mr. Herman holds an MBA degree from Kellogg School of Management and an undergraduate degree from Baldwin Wallace University School of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
REPARE THERAPEUTICS INC.
0,01% | 01/04/2024 | 3 924 ( 0,01% ) | 12 361 $ | 30/04/2024 |
Postes actifs de Philip Herman
Sociétés | Poste | Début |
---|---|---|
REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 05/01/2022 |
Anciens postes connus de Philip Herman
Sociétés | Poste | Fin |
---|---|---|
Y-MABS THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2021 |
VANDA PHARMACEUTICALS INC. | Sales & Marketing | - |
DYAX CORP. | Sales & Marketing | - |
Formation de Philip Herman
Kellogg School of Management | Masters Business Admin |
Baldwin Wallace University School of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
Y-MABS THERAPEUTICS, INC. | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
VANDA PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Dyax Corp.
Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |